BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12559023)

  • 1. Leukapheresis after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: a novel approach to harvest a second autograft.
    Schwella N; Braun A; Ahrens N; Rick O; Salama A
    Transfusion; 2003 Feb; 43(2):259-64. PubMed ID: 12559023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood progenitor cell collection during hematopoietic recovery following autologous blood progenitor cell transplantation.
    Schwella N; Kingreen D; Heuft HG; Oettle H; Rick O; Serke S; Huhn D; Siegert W
    Vox Sang; 1997; 72(2):118-20. PubMed ID: 9088081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
    Tarella C; Di Nicola M; Caracciolo D; Zallio F; Cuttica A; Omedè P; Bondesan P; Magni M; Matteucci P; Gallamini A; Pileri A; Gianni AM
    Bone Marrow Transplant; 2002 Dec; 30(11):725-32. PubMed ID: 12439694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.
    Schwella N; Beyer J; Schwaner I; Heuft HG; Rick O; Huhn D; Serke S; Siegert W
    J Clin Oncol; 1996 Apr; 14(4):1114-21. PubMed ID: 8648365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution.
    Schwella N; Siegert W; Beyer J; Rick O; Zingsem J; Eckstein R; Serke S; Huhn D
    Ann Hematol; 1995 Nov; 71(5):227-34. PubMed ID: 7492625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation.
    Heuft HG; Dubiel M; Kingreen D; Oertel J; De Reys S; Rick O; Serke S; Schwella N
    Vox Sang; 2000; 79(2):94-9. PubMed ID: 11054047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation.
    Pérez-Simón JA; Caballero MD; Corral M; Nieto MJ; Orfao A; Vazquez L; Amigo ML; Berges C; González M; Del Cañizo C; San Miguel JF
    Transfusion; 1998 Apr; 38(4):385-91. PubMed ID: 9595022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?
    Gidron A; Verma A; Doyle M; Boggio L; Evens A; Gordon L; Singhal S; Tallman M; Williams S; Winter J; Mehta J
    Bone Marrow Transplant; 2005 Feb; 35(3):243-6. PubMed ID: 15580281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim.
    Moncada V; Bolan C; Yau YY; Leitman SF
    Transfusion; 2003 Apr; 43(4):495-501. PubMed ID: 12662283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
    Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
    J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for successful mobilization of peripheral blood progenitor cells with ESHAP + G-CSF in patients with pretreated non-Hodgkin's lymphoma.
    Liu JH; Chen CC; Bai LY; Chao SC; Chang MS; Lin JS
    J Chin Med Assoc; 2008 Jun; 71(6):279-85. PubMed ID: 18567557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization and harvesting of peripheral blood stem cells in pediatric patients with solid tumors.
    Veljkovic D; Vujic D; Nonkovic OS; Jevtic D; Zecevic Z; Lazic E
    Ther Apher Dial; 2011 Dec; 15(6):579-86. PubMed ID: 22107695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intermittent- and continuous-flow cell separators for the collection of autologous peripheral blood progenitor cells in patients with hematologic malignancies.
    Hitzler WE; Wolf S; Runkel S; Kunz-Kostomanolakis M
    Transfusion; 2001 Dec; 41(12):1562-6. PubMed ID: 11778073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.
    Delamain MT; Metze K; Marques JF; Reis AR; De Souza CA; Lorand-Metze I
    Transfus Apher Sci; 2006 Feb; 34(1):33-40. PubMed ID: 16376618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.
    Benjamin RJ; Linsley L; Axelrod JD; Churchill WH; Sieff C; Shulman LN; Elias A; Ayash L; Malachowski ME; Uhl L
    Transfusion; 1995 Oct; 35(10):837-44. PubMed ID: 7570914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
    Weaver CH; Schwartzberg L; Li W; Hazelton B; West W
    Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two leukapheresis programs for computerized collection of blood progenitor cells on a new cell separator.
    Schwella N; Movassaghi K; Scheding S; Ahrens N; Salama A
    Transfusion; 2003 Jan; 43(1):58-64. PubMed ID: 12519431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
    Moskowitz CH; Glassman JR; Wuest D; Maslak P; Reich L; Gucciardo A; Coady-Lyons N; Zelenetz AD; Nimer SD
    Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
    Bruns I; Steidl U; Kronenwett R; Fenk R; Graef T; Rohr UP; Neumann F; Fischer J; Scheid C; Hübel K; Haas R; Kobbe G
    Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.